BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ESR1, ESR, 2099, ENSG00000091831, RP1-130E4_1, NR3A1, ESRA, DKFZp686N23123, ER, Era
90986 results:

  • 1. Large enrichments in fatty acid
    Maloney AE; Kopf SH; Zhang Z; McFarlin J; Nelson DB; Masterson AL; Zhang X
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2310771121. PubMed ID: 38709917
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nanoparticle/Engineered Bacteria Based Triple-Strategy Delivery System for Enhanced Hepatocellular Carcinoma cancer Therapy.
    Yang M; Chen W; Gupta D; Mei C; Yang Y; Zhao B; Qiu L; Chen J
    Int J Nanomedicine; 2024; 19():3827-3846. PubMed ID: 38708180
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predicting effect of anti-PD-1/PD-L1 inhibitors therapy for hepatocellular carcinoma by detecting plasma metabolite based on UHPLC-MS.
    Liu B; Shi J; Su R; Zheng R; Xing F; Zhang Y; Wang N; Chen H; Feng S
    Front Immunol; 2024; 15():1370771. PubMed ID: 38707906
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.
    Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME
    J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.
    Pourfaraji SM; Moghadam MN; Moradi AM; Shirmard FO; Mohammadzadeh N; Jafarian A
    BMC Surg; 2024 May; 24(1):131. PubMed ID: 38702645
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).
    Lacombe K; Moh R; Chazallon C; Lemoine M; Sylla B; Fadiga F; Le Carrou J; Marcellin F; Kouanfack C; Ciaffi L; Sartre MT; Sida MB; Diallo A; Gozlan J; Seydi M; Cissé V; Danel C; Girard PM; Toni TD; Minga A; Boyer S; Carrieri P; Attia A;
    Sci Rep; 2024 May; 14(1):10244. PubMed ID: 38702350
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
    Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
    Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Feng J; Zhao Y; Zhai L; Zhou J
    Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study.
    Jia W; Wu Q; Li R; Hou S; Kang C
    Medicine (Baltimore); 2024 May; 103(18):e37984. PubMed ID: 38701255
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Heavy metal levels and human health risk implications associated with fish consumption from the lower Omo river (Lotic) and Omo delta lake (Lentic), Ethiopia.
    Kotacho AA; Yimer GT; Sota SS; Berego YS
    PeerJ; 2024; 12():e17216. PubMed ID: 38699190
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
    Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
    Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.
    Jiang C; Liu W; Jin Z; Lan L; Xu L; Du A; Peng S; Zeng Y; Wang H; Liao M; Zhou J
    Cancer Med; 2024 May; 13(9):e7222. PubMed ID: 38698687
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma.
    Xiong KG; Ke KY; Kong JF; Lin TS; Lin QB; Lin S; Zhu YY
    World J Surg Oncol; 2024 May; 22(1):117. PubMed ID: 38698475
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of TikTok videos on acute pancreatitis: content quality and reliability analysis.
    Mao T; Zhao X; Jiang K; Yang J; Xie Q; Fu J; Du B; Lei Z; Gao F
    BMC Public Health; 2024 May; 24(1):1216. PubMed ID: 38698404
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.
    Vaghiri S; Lehwald-Tywuschik N; Prassas D; Safi SA; Kalmuk S; Knoefel WT; Dizdar L; Alexander A
    Langenbecks Arch Surg; 2024 May; 409(1):149. PubMed ID: 38698255
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression of Fascin-1 and its diagnostic value in liver cancer.
    Lu SP; Jiang LJ; Wang Y; Shao JK; Du ZQ; Huang BF; Wang CQ
    Sci Rep; 2024 May; 14(1):10049. PubMed ID: 38698008
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.
    Tan N; Ngu N; Worland T; Lee T; Abrahams T; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson AJ; Ding JN; Nicoll AJ; Liu K; Pandya K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38696372
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bioaccumulation and health risk assessment of trace elements in Tilapia (Oreochromis mossambicus) from selected inland water bodies.
    Balamanikandan V; Shalini R; Arisekar U; Shakila RJ; Padmavathy P; Sivaraman B; Devanesan S; Sundhar S; AlSalhi MS; Mythili R; Kim W
    Environ Geochem Health; 2024 May; 46(6):187. PubMed ID: 38696018
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics.
    Yang Y; Wang H; Si J; Zhang L; Ding H; Wang F; He L; Chen X
    J Cancer Res Clin Oncol; 2024 Apr; 150(5):223. PubMed ID: 38691204
    [TBL] [Abstract] [Full Text] [Related]  

  • 20.
    Waziri P; Auta R; Imam MU; Chindo BA; Ladan Z; Mohammed Z; Wayah S; Mohammed J; Tahir MI; Ahmad AE; Alhassan Y; Tyoapine D; Agbaji AS
    J Evid Based Integr Med; 2024; 29():2515690X241251558. PubMed ID: 38689490
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4550.